2018 annual financial data
BioMarin Pharmaceutical 2018 Operating margin
BioMarin Pharmaceutical 2018 operating margin with verified reported values.
Direct answer
Operating margin was -8.28%.
Operating income was -123,524,000 USD and net income was -77,211,000 USD.
Operating cash flow was 20,208,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,491,256,000 USD
- Operating income
- -123,524,000 USD
- Net income
- -77,211,000 USD
- Operating cash flow
- 20,208,000 USD